# A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants

> **NCT04320745** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 168 (actual)

## Conditions studied

- Hypogonadism

## Interventions

- **DRUG:** Androderm®

## Key facts

- **NCT ID:** NCT04320745
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-19
- **Primary completion:** 2021-06-24
- **Final completion:** 2021-06-24
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2022-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04320745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04320745, "A Study to Evaluate Androderm®'s Effect on Blood Pressure in Adult Hypogonodal Male Participants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04320745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*